There were 362 patients recruited from April 2019 till January 2020 and 118 cases of these 362 patients with polyp(s) detected at colonoscopy were eventually randomized into the study (Fig. 1). A total number of 236 polyps were detected for the whole group, but 9 polyps (3 of 130 polyps in group A, 6 of 106 polyps in group B) were lost during the process of retrieval leaving 227 polyps eventually available for pathological assessment. The missing polyps were not significantly difference between the two groups (Chi-square p = 0.345).
Among the 227 polyps, 144 (63.4%) of the polyps were adenoma, 79 (34.8%) were hyperplastic polyps and 4 (1.7%) were cancer according to histological results. There were no SSAPs detected in this study. The most common site of polyps’ location was sigmoid colon (30%) and 188 of 227 (82.8%) polyps were diminutive type. The polyp detection rate (PDR) and adenoma detection rate (ADR) for the whole group of 362 patients were 118 of 362 (32.5%) and 86 of 362 (23.7 %) respectively.
Sixty-two patients with 130 polyps including 3 lost polyps leaving 127 polyps available were assigned to group A and 56 patients with 106 polyps including 6 lost polyps leaving 100 polyps available were allocated to group B (Fig. 1). There was no significant difference between the two groups regarding age, sex, indications for colonoscopy, total procedure time, withdrawal time, cecal intubation rate, complication rate, polyp size, polyp morphology, polyp histology and polyp locations (Table 1). The quality of bowel preparation in group A was significantly better than group B (P = 0.01). There were 76 adenomatous polyps and 2 cancers by histology in group A and 68 adenomatous polyps and 2 cancers in group B, but the differences were not statistically significant (P = 0.433).
Primary end point (Table 2.)
Table 2
Accuracy, sensitivity, specificity, PPV and NPV of NICE criteria in group A and B.
| Near-focus (A) n = 127 | 95% CI | Normal-focus (B) n = 100 | 95% CI | p-value |
Neoplastic (n = 149) | 79 | | 70 | | |
Accuracy | 76 | 67–83 | 71 | 61–80 | 0.522 |
Sensitivity | 72 | 61–82 | 66 | 53–77 | 0.445 |
Specificity | 81 | 67–91 | 83 | 65–94 | 0.854 |
PPV | 86 | 76–94 | 90 | 79–97 | 0.514 |
NPV | 64 | 51–76 | 51 | 36–66 | 0.086 |
Hyperplastic polyp (n = 78) | 48 | | 30 | | |
Accuracy | 76 | 67–83 | 71 | 61–80 | 0.522 |
Sensitivity | 81 | 67–91 | 83 | 65–94 | 0.854 |
Specificity | 72 | 61–82 | 66 | 53–77 | 0.445 |
PPV | 64 | 51–76 | 51 | 36–66 | 0.086 |
NPV | 86 | 76–94 | 90 | 79–97 | 0.514 |
Adenomatous polyp (n = 144) | 76 | | 68 | | |
Accuracy | 75 | 66–82 | 69 | 59–78 | 0.431 |
Sensitivity | 70 | 58–80 | 62 | 49–73 | 0.296 |
Specificity | 82 | 69–92 | 84 | 67–95 | 0.851 |
PPV | 85 | 74–93 | 89 | 77–96 | 0.528 |
NPV | 65 | 52–76 | 51 | 37–65 | 0.063 |
PPV: positive predictive value; NPV: negative predictive value |
The accuracy, sensitivity, specificity, PPV, and NPV of NICE in optical diagnosis of neoplastic polyps were 76%, 72%, 81%, 86%, 64%, respectively in group A and 71%, 66%, 83%, 90%, 51%, respectively in group B. The performance of NF NBI was not better than SF NBI in optical diagnosis of neoplastic polyps (p = 0.522, p = 0.445, p = 0.854, p = 0.514 and p = 0.086, respectively). NPV in NF NBI was higher than SF NBI, even though, it was statistically not significantly different (p = 0.086).
The accuracy, sensitivity, specificity, PPV, and NPV of NICE to diagnose hyperplastic polyps were 76%, 81%, 72%, 64%, 86% in group A and 71%, 83%, 66%, 51%, 90% in group B, however, there were no significant difference in performance between NF NBI and SF NBI in terms of optical diagnosis (p = 0.522, p = 0.854, 0.445, 0.086, 0.514, respectively).
The accuracy, sensitivity, specificity, PPV, and NPV of NICE in diagnosis of adenomatous polyps were 75%, 70%, 82%, 85%, 65% in group A and 69%, 62%, 84%, 89%, 51% in group B, even though, there were no significant difference between NF NBI compared with SF NBI (p = 0.431, p = 0.296, 0.851, 0.528, 0.063, respectively), but the NPV of NF NBI was higher than SF NBI showing a trend of NF NBI superior to SF NBI (p = 0.063).
Outcome measure according to interobserver variations.
The capability of each endoscopist in optical diagnosis of polyps using the NICE classification (excluding WASP for SSAPs) compared with histological analysis by using Cohen’s K-coefficient was 79.21% (Kappa = 0.579) for endoscopist I, 64.58% (Kappa = 0.431) for endoscopist II, 54.55% (Kappa = -0.009) for endoscopist III, and 50% (Kappa = 0.213) for endoscopist IV.
The accuracy of NICE classification for optical diagnosis of neoplastic polyps of the whole group (A and B) by the endoscopists with higher Kappa (Kappa 0.579 and 0.431) was 76%, it was significantly higher than 57% by the endoscopists with lower Kappa (Kappa 0.0213 and − 0.0009) (p = 0.007). The accuracy of the NICE classification in optical diagnosis of neoplastic polyps by the endoscopists with higher Kappa was 79 % in group A, and was higher than 71 % in group B, however the difference was not significant (p = 0.253) (Table 3), whereas the accuracy of optical diagnosis by the NICE classification for neoplastic polyps by the endoscopists with lower Kappa was 55 % in group A that was lower than 60 % in group B, but the difference failed to reach statistical significance (p = 0.567) (Table 4).
Table 3
Accuracy, sensitivity, specificity, PPV and NPV by NICE criteria of the endoscopists with higher Kappa in optical diagnosis of polyps.
| Near-focus (A) n = 95 | 95% CI | Normal-focus (B) n = 82 | 95% CI | p-value |
Neoplastic (n = 113) | 58 | | 55 | | |
Accuracy | 79 | 71–86 | 71 | 60–80 | 0.253 |
Sensitivity | 75 | 63–84 | 65 | 52–77 | 0.165 |
Specificity | 86 | 72–95 | 83 | 65–94 | 0.696 |
PPV | 90 | 79–96 | 89 | 75–96 | 1.000 |
NPV | 67 | 53–79 | 54 | 39–69 | 0.083 |
Hyperplastic polyp (n = 64) | 37 | | 27 | | |
Accuracy | 79 | 70–86 | 71 | 61–80 | 0.253 |
Sensitivity | 86 | 72–95 | 83 | 65–94 | 0.696 |
Specificity | 75 | 63–84 | 65 | 52–77 | 0.165 |
PPV | 67 | 53–79 | 54 | 39–69 | 0.083 |
NPV | 90 | 79–96 | 89 | 75–96 | 1.000 |
Adenomatous polyp (n = 108) | 55 | | 53 | | |
Accuracy | 78 | 70–85 | 69 | 58–78 | 0.199 |
Sensitivity | 72 | 60–83 | 60 | 47–73 | 0.101 |
Specificity | 87 | 74–95 | 84 | 67–95 | 0.688 |
PPV | 89 | 78–96 | 88 | 73–96 | 1.000 |
NPV | 68 | 54–79 | 54 | 39–68 | 0.059 |
PPV: positive predictive value; NPV: negative predictive value |
Table 4
Accuracy, sensitivity, specificity, PPV and NPV by NICE criteria of the endoscopists with lower Kappa in optical diagnosis of polyps.
| Near-focus (A) n = 32 | 95% CI | Normal-focus (B) n = 18 | 95% CI | p-value |
Neoplastic (n = 36) | 21 | | 15 | | |
Accuracy | 55 | 35–75 | 60 | 32–84 | 0.567 |
Sensitivity | 41 | 18–67 | 58 | 28–85 | 0.023 |
Specificity | 80 | 44–97 | 67 | 9–99 | 0.054 |
PPV | 78 | 40–97 | 88 | 47–100 | 0.090 |
NPV | 44 | 22–69 | 29 | 4–71 | 0.039 |
Hyperplastic polyp (n = 14) | 11 | | 3 | | |
Accuracy | 55 | 35–74 | 60 | 32–84 | 0.567 |
Sensitivity | 80 | 44–97 | 67 | 9–99 | 0.054 |
Specificity | 41 | 18–67 | 58 | 28–85 | 0.024 |
PPV | 44 | 22–69 | 29 | 4–71 | 0.039 |
NPV | 78 | 40–97 | 88 | 47–100 | 0.090 |
Adenomatous polyp (n = 36) | 21 | | 15 | | |
Accuracy | 55 | 35–75 | 57 | 41–72 | 0.567 |
Sensitivity | 41 | 18–67 | 48 | 29–67 | 0.024 |
Specificity | 80 | 44–97 | 77 | 46–95 | 0.054 |
PPV | 78 | 40–97 | 82 | 57–96 | 0.090 |
NPV | 44 | 22–69 | 40 | 21–61 | 0.039 |
PPV: positive predictive value; NPV: negative predictive value |
The sensitivity and NPV of NICE classification in predicting neoplastic polyps of the whole group (A and B) by the endoscopist with higher Kappa were 72 % and 62 %, these were significantly higher than 48 % and 49 % by the endoscopists with lower Kappa (p = 0.002 and p = 0.004, respectively), but the specificity and PPV were not different between the two groups of endoscopists, namely 83 % and 88 % for the endoscopists with higher Kappa compared with 77 % and 82 % for the endoscopists with lower Kappa; (p = 0.207 and p = 0.228, respectively).
The sensitivity, specificity, PPV, and NPV of NICE classification in predicting neoplastic polyps by the endoscopists with higher Kappa were 75%, 86%, 90%, 67% in group A and 65%, 83%, 89%, 54% in group B, respectively, but they were not significantly difference. (p = 0.165, p = 0.696, p = 1.000 and p = 0.083, respectively). The sensitivity, specificity, PPV, and NPV of NICE classification in predicting neoplastic polyps by the endoscopists with lower Kappa were 41%, 80%, 78%, 44% in group A and 58%, 67%, 88%, 29% in group B, respectively. The 41% sensitivity in group A was significantly lower than 58% in group B, in contrary, the 44% NPV of group A was significantly higher than 29% NPV in group B (p = 0.023 and p = 0.039, respectively), however, there were no significant difference of specificity and PPV between the two groups (p = 0.054 and p = 0.090, respectively).
For diminutive polyps.
There were no statistical differences regarding accuracy, sensitivity, specificity, PPV and NPV in optical diagnosis of diminutive neoplastic polyps, hyperplastic polyps and adenomas between group A and group B (Table 5.) When performance was assessed by comparing the whole group (A and B) with diminutive group (A and B), the accuracy, sensitivity, specificity, PPV and NPV of NICE classification in predicting neoplastic polyps were 74%, 69%, 82%, 88%, 58% for the whole group and were 68%, 59%, 82%, 82%, 58% for the diminutive group, nevertheless, the differences were not significant (Chi-square test, p = 0.436, p = 0.185, p = 1.000, p = 0.322, and p = 1.000, respectively).
Table 5
Accuracy, sensitivity, specificity, PPV and NPV by NICE criteria in the polyps ≤ 5 mm.
| Near-focus (A) n = 109 | 95%CI | Normal-focus (B) n = 78 | 95%CI | p-value |
Neoplastic (n = 110) | 61 | | 49 | | |
Accuracy | 72 | 62–79 | 64 | 52–74 | 0.289 |
Sensitivity | 64 | 51–76 | 53 | 38–67 | 0.151 |
Specificity | 81 | 67–91 | 83 | 64–94 | 0.854 |
PPV | 81 | 67–91 | 84 | 66–95 | 0.709 |
NPV | 64 | 51–76 | 51 | 36–66 | 0.086 |
Hyperplastic polyp (n = 77) | 48 | | 29 | | |
Accuracy | 72 | 62–79 | 64 | 52–75 | 0.289 |
Sensitivity | 81 | 67–91 | 83 | 64–94 | 0.854 |
Specificity | 64 | 51–76 | 53 | 38–67 | 0.151 |
PPV | 64 | 51–76 | 51 | 66–95 | 0.709 |
NPV | 72 | 62–79 | 64 | 52–75 | 0.289 |
Adenomatous polyp (n = 108) | 59 | | 49 | | |
Accuracy | 71 | 62–79 | 61 | 49–72 | 0.179 |
Sensitivity | 63 | 49–75 | 49 | 34–64 | 0.064 |
Specificity | 82 | 69–91 | 83 | 64–94 | 1.000 |
PPV | 80 | 66–91 | 83 | 64–94 | 0.716 |
NPV | 65 | 52–77 | 49 | 34–64 | 0.032 |
Outcome of WASP criteria in sessile polyps.
The WASP criteria classified polyps as serrated polyps in 31 (15.9%), however, the histology did not confirm the diagnosis in all 31 polyps. The pathological examinations of polyps classified as serrated polyps by WASP criteria were hyperplastic polyps in 11 and adenomatous polyps in 20. In group A, WASP criteria falsely diagnosed 22% (25 out of 113 polyps) SSAPs whereas in group B, false diagnoses were 7.4% (6 out of 81 polyps) and the difference was statistically significant (p = 0.011). Of these 31 polyps classified as serrated polyps by WASP criteria, 25 polyps had 2 features and 6 polyps had 4 features of SSAPs.
Optical Diagnosis Missed classification (Table 6.).
Table 6
Optical diagnostic accuracy of polyps by NICE classification in group A and group B.
| | Hyperplastic polyp | Adenomatous polyp | Deep invasive cancer | p-value |
Group A | NICEI (n = 61) | 40 (65.6) | 20 (32.8) | 1 (1.6) | |
Group B | NICEI (n = 49) | 25 (51) | 24 (49) | 0 (0) | 0.164 |
Group A | NICEII(n = 62) | 9 (14.5) | 53 (85.5) | 0 (0) | |
Group B | NICEII(n = 47) | 5 (10.6) | 42 (89.4) | 0 (0) | 0.756 |
Group A | NICEIII (n = 4) | 0 (0) | 3 (75) | 1 (25) | |
Group B | NICEIII (n = 4) | 0 (0) | 2 (50) | 2 (50) | NA |
NICE I misclassified adenomatous polyps as hyperplastic polyps in 20 (32.8%) in group A and 24 (49%) polyps in group B and 1 cancer as hyperplastic polyps (1.6%) in group A (Chi’s square test, p < 0.164).
NICE II misclassified hyperplastic polyps as adenomatous polyps in 9 (14.5%) polyps in group A and 5 (10.6%) polyps in group B. (Chi’s square test, p < 0.756).
NICE III misclassified 3 adenomatous polyp as malignant lesions in group A and misclassified 2 adenomatous polyps as malignant lesions in group B. No statistical analysis was attempted since the number of misclassifications were too small.